CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):

 

 

 

(Address of Principal Executive Offices)

 

(Registrant’s Telephone number)

 

Copies to:

Asher S. Levitsky PC

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas, Suite 1100

New York, New York 10105

Phone: (646) 895-7152

Fax: (646) 895-7238

E-mail:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by a check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Securities registered pursuant to Section 12(b) of the Act: None

 

 

 

On February 27, 2020, the Company entered into a termination agreement and mutual release with Dr. Albert Maarek, Irina Maarek, Rudy Maarek and Richard Clement, the owners of all of the equity interest in LD Technology, LLC and Medical Screening, Inc., pursuant to which the parties agreed to a termination of the stock purchase agreement dated August 22, 2019, pursuant to which the Company was to acquire all of the equity interest in these two companies, and to a release of their respective obligations under the stock purchase agreement. The termination agreement and mutual release did not affect the Company’s distribution agreement with LD Technology, LLC, which remains in effect.

 

 

 

 

  

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.